GBUK Group, a portfolio company of A&M Capital Europe (“AMCE”), a London-based private equity firm with €650 million of commitments under management, has acquired UK-based Severn Healthcare Technologies (“Severn”), a value-added and fast-growing distributor of single-use medical devices.
Founded in 2014, Severn specialises in providing next-generation single-use medical devices across the Ear, Nose, and Throat (“ENT”) and Neuro-Otology clinical specialisms. Supporting the adoption of clinical innovation in operating theatres across the National Health Service (“NHS”) and the UK Private market, we believe Severn has built a reputation as a trusted partner to surgical clinicians on the foundations of deep technical expertise and exceeding customer service.
The acquisition of Severn represents GBUK’s second acquisition since AMCE’s investment in December 2023. The acquisition is expected to strengthen GBUK’s clinical specialist positioning further while expanding its product presence in two new and innovative therapeutic areas.
GBUK were advised by Rothschild & Co as financial adviser, Burness Paull as legal adviser, Accuracy as accounting adviser, and PMSI as commercial adviser.
About GBUK Group
Headquartered in the United Kingdom, GBUK Group designs develops and distributes a comprehensive portfolio of own and third-party branded acute-setting medical devices across enteral feeding, vascular access, patient handling and the broader critical care environment. The Company is a top 20 supplier to the UK NHS and supports healthcare professionals and patients in over 45 countries with more than 600,000 medical devices daily. GBUK Group has demonstrated a track record of penetrating new care areas by leveraging its R&D capabilities and a high-touch sales model hinged on wrap-around services. To find out more, visit www.gbukgroup.com.
About A&M Capital Europe
AMCE is a London-headquartered private equity investment firm specialising in building pan-European platform companies through buy-and-build and organic growth initiatives. AMCE Fund I currently has €650 million of commitments under management, and Severn represents AMCE’s twenty-third transaction across its eight portfolio companies. More broadly, AMCE is part of A&M Capital, a multi-strategy private equity investment firm that manages commitments totalling ~€5.5 billion across all its investment strategies. In addition, A&M Capital maintains a strategic association with Alvarez & Marsal, one of the world’s largest growth and operationally focused advisory firms. For additional information, please visit A&M Capital Europe’s website at www.a-mcapital.com.